| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.129 | 4.061 | 5.196 | 4.725 | 11.785 | 8.893 | 17.156 | 18.554 |
| Total Income - EUR | - | - | 1.129 | 4.061 | 5.196 | 4.725 | 11.785 | 8.893 | 17.156 | 21.300 |
| Total Expenses - EUR | - | - | 27 | 53 | 74 | 345 | 490 | 851 | 832 | 1.028 |
| Gross Profit/Loss - EUR | - | - | 1.102 | 4.009 | 5.122 | 4.380 | 11.295 | 8.042 | 16.324 | 20.272 |
| Net Profit/Loss - EUR | - | - | 1.068 | 3.887 | 4.966 | 4.250 | 10.984 | 7.815 | 14.104 | 17.515 |
| Employees | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dermoconsult Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 1.173 | 5.236 | 10.149 | 14.341 | 25.212 | 33.397 | 48.217 | 68.815 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 443 | 857 | 1.096 | 558 | 772 | 1.254 | 1.368 | 4.701 |
| Cash | - | - | 729 | 4.379 | 9.053 | 13.783 | 24.441 | 32.143 | 46.849 | 64.113 |
| Shareholders Funds | - | - | 1.112 | 4.978 | 9.848 | 13.912 | 24.587 | 32.478 | 46.484 | 63.739 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 114 | 258 | 301 | 429 | 625 | 919 | 1.733 | 5.075 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Dermoconsult Clinique S.r.l.